Back
AbCellera Biologics Vs. Digimarc Industry Stock Comparison
Buy
52
ABCL
AbCellera Biologics
Last Price:
$3.06
Seasonality Move:
-25.1%
Buy
69
DMRC
Digimarc
Last Price:
$44.91
Seasonality Move:
-0.46%
Buy
52
AbCellera Biologics (ABCL)
is a Buy
Is AbCellera Biologics a Buy, Sell or Hold?
-
The current AbCellera Biologics [ABCL] share price is $3.28. The Score for ABCL is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
ABCL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ABCL Stock Price Chart
What is AbCellera Biologics's stock price today?
-
The AbCellera Biologics share price today is $3.28The current trend is moderately bullish and ABCL is experiencing selling pressure, which indicates risk of future bearish movement.
DMRC Stock Price Chart
ABCL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 63.98 | Buy |
Chaikin Money Flow: | -3228664 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.8 - 3.08) | Buy |
Bollinger Bands (100): | (2.55 - 2.93) | Buy |
DMRC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.95 | Buy |
Relative Strength Index (14 RSI): | 77.81 | Buy |
Chaikin Money Flow: | -50271 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.04 - 41.56) | Buy |
Bollinger Bands (100): | (26.95 - 36.11) | Buy |
ABCL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.07 | Buy |
20-day SMA: | 2.95 | Buy |
50-day SMA: | 2.88 | Buy |
200-day SMA: | 3.16 | Buy |
8-day EMA: | 3.1 | Buy |
20-day EMA: | 2.99 | Buy |
50-day EMA: | 2.89 | Buy |
200-day EMA: | 3.33 | Sell |
DMRC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.75 | Buy |
20-day SMA: | 38.6 | Buy |
50-day SMA: | 34.92 | Buy |
200-day SMA: | 29.48 | Buy |
8-day EMA: | 42.91 | Buy |
20-day EMA: | 39.47 | Buy |
50-day EMA: | 35.85 | Buy |
200-day EMA: | 31.56 | Buy |
AbCellera Biologics Earnings Growth & ABCL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and an increase next year of $0.11 per share.
Digimarc Earnings Growth & DMRC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and a decrease next year of $0.00 per share.
AbCellera Biologics Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Digimarc Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |